Genvor Incorporated (GNVR)
| Market Cap | 8.08K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.43M |
| Shares Out | 20.20M |
| EPS (ttm) | -0.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 200 |
| Open | 0.0004 |
| Previous Close | 0.0004 |
| Day's Range | 0.0004 - 0.0004 |
| 52-Week Range | 0.0004 - 3.7500 |
| Beta | n/a |
| RSI | 0.03 |
| Earnings Date | May 12, 2025 |
About Genvor
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company was formerly known as Allure Worldwide, Inc. and changed its name to Genvor Incorporated in June 2022. Genvor Incorporated is headquartered in Chapel Hill, North Carolina. [Read more]
Financial Performance
Financial StatementsNews
Genvor to Unveil Latest Research on Patented Peptides for Aflatoxin Resistance in Corn at BioAgTech World Congress
Genvor's Research Enabled by R&D Agreement with USDA's Agricultural Research Service, Focused on Driving Solutions to the Nation's Most Pressing Agricultural Problems CHAPEL HILL, NC / ACCESSWIRE / Ap...
Genvor to Participate in BioAgTech World Congress in Raleigh, North Carolina
CHAPEL HILL, NC / ACCESSWIRE / April 2, 2024 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a developer of sustainable plant health solutions leveraging patented peptides, today annou...
Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco
Genvor Presenting as a Featured Startup at Leading Global AgTech Event CHAPEL HILL, NC / ACCESSWIRE / February 27, 2024 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a developer of s...
Genvor to Attend BioSolutions Conference & Expo in Visalia, California
Genvor to Showcase Next-Generation Plant Health Solutions at Leading Industry Event CHAPEL HILL, NC / ACCESSWIRE / February 20, 2024 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a d...
Genvor Provides Fiscal First Quarter 2024 Corporate Update
New CEO Appointment and OTCQB Venture Market Listing to Drive Commercialization Momentum Ahead of Planned FY25 Uplisting CHAPEL HILL, NC / ACCESSWIRE / February 15, 2024 / Genvor Incorporated (OTCQB:G...
Genvor Appoints Veteran Agribusiness Leader Chad Pawlak as Chief Executive Officer
Judith Miller to Transition to Chief Business Officer CHAPEL HILL, NC / ACCESSWIRE / January 17, 2024 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a developer of sustainable plant h...
USDA and Genvor Scientists Publish Research Highlighting Broad-Spectrum Efficacy of Genvor's Antimicrobial Peptides
Paper Serves as Validation by USDA Scientists That Genvor AMPs are Highly Effective Against Harmful Fungi CHAPEL HILL, NC / ACCESSWIRE / December 18, 2023 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" ...
Genvor Begins Trading on the OTCQB Venture Market
Innovative Developer of Sustainable Plant Health Solutions Enters the Public Markets CHAPEL HILL, NC / ACCESSWIRE / December 5, 2023 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a d...
Genvor Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
CHAPEL HILL, NC / ACCESSWIRE / November 6, 2023 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a developer of sustainable plant health solutions leveraging patented peptides, today an...